5th to 7th September 2016, Church House Conference Centre, London
A scientific and educational meeting showcasing state-of-the-art translational science in childhood cancer
Childhood Cancer 2016, chaired by Dr Nick Goulden, combined an outstanding line-up of plenary speakers with free communication and panel debates to address three themes over three days:
Is precision medicine a reality for children with cancer in 2016?
Chaired by Professor David Walker and Professor Louis Chesler
Can we harness the power of the immune system to cure childhood cancer?
Chaired by Professor Persis Amrolia and Professor John Anderson
What do we know about influenceable causes of childhood cancer?
Chaired by Professor Denis Henshaw and Professor Tariq Enver
Dr Nick Goulden
The format of the meeting was designed to facilitate the sharing of information and knowledge, providing a forum for the discussion of important issues, networking and the development of new collaborations.
In total, around 150 delegates and speakers participated in the meeting over the three days and we achieved our aim of bringing together a broad range of scientists and clinicians from different areas of childhood cancer research and care.
What the delegates said:
An excellent conference - congratulations!
Some really brilliant talks, very stimulating format. Thank you, it was a great conference.
The day I attended was useful to me and the overall attendee list was very strong. Clearly it attracted leaders in the field and it was an interactive setting and good for networking.
Thoroughly enjoyed it and will definitely come to the next one.
The meeting was a good size with excellent speakers, good quality presentations. The debates at the end of each day were extremely useful. The online voting during sessions allowing audience participation was a great idea!
Submitted abstracts and invited speaker abstracts are now available to download on the Abstracts page
Childhood Cancer 2017
Planning is already underway for Childhood Cancer 2017, which will take place next autumn. Childhood Cancer 2017 will be a two-day meeting focused on translational research for patient benefit. Further details will be published shortly.